To investigate the mechanisms underlying the cardiac hypertrophy induced by FARS2 ablation, we next examined the myocardial and mitochondrial functions in the early and late stages (3 and 10 weeks after icKO, respectively) in icKO and WT control littermates (Figure 3A). This evidence concerns the gene FARS2 and cardiac hypertrophy.